Amanda K. Psyrri

Amanda K. Psyrri

Athens, ESYE31 12461, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 210 publications

Biopsy-Confirmed Acute Interstitial Nephritis in Patients Treated with Immune Checkpoint Inhibitors: A Single-Center Retrospective Case Series.

Biopsy-Confirmed Acute Interstitial Nephritis in Patients Treated with Immune Checkpoint Inhibitors: A Single-Center Retrospective Case Series.

Journal: Antibodies (Basel, Switzerland)

Published: June 08, 2026

AXL-mRNA Overexpression in Size-Based Enriched Circulating Tumor Cells as a Potential Biomarker for Anti-AXL Targeted Therapies in Non-Small-Cell Lung Cancer.

AXL-mRNA Overexpression in Size-Based Enriched Circulating Tumor Cells as a Potential Biomarker for Anti-AXL Targeted Therapies in Non-Small-Cell Lung Cancer.

Journal: Cancers

Published: May 06, 2026

Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.

Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.

Journal: Cancer treatment reviews

Published: April 28, 2026

Postbleeding antithrombotic management in cardiovascular patients: insights from the Attica Bleeding Snapshot study.

Postbleeding antithrombotic management in cardiovascular patients: insights from the Attica Bleeding Snapshot study.

Journal: Research and practice in thrombosis and haemostasis

Published: April 16, 2026

JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCC.

JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCC.

Journal: Future oncology (London, England)

Published: January 30, 2026

Correction: Anastasiou et al. MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients. Pharmaceuticals 2025, 18, 1908.

Correction: Anastasiou et al. MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients. Pharmaceuticals 2025, 18, 1908.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 28, 2026

Different Pattern of Treatment Failure After Chemoradiation Between p16+ and p16- Patients Affected by Oropharyngeal Carcinoma.

Different Pattern of Treatment Failure After Chemoradiation Between p16+ and p16- Patients Affected by Oropharyngeal Carcinoma.

Journal: Head & neck

Published: December 12, 2025

Wernicke's encephalopathy in a patient with adenoid cystic carcinoma: case report and literature review.

Wernicke's encephalopathy in a patient with adenoid cystic carcinoma: case report and literature review.

Journal: Frontiers in oncology

Published: October 12, 2025

Immune-mediated liver injury caused by checkpoint inhibitors: A case series and review of the literature.

Immune-mediated liver injury caused by checkpoint inhibitors: A case series and review of the literature.

Journal: Experimental and therapeutic medicine

Published: October 07, 2025

MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients.

MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 30, 2025

Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study.

Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 03, 2025

Advances in Prevention, Screening, and Early Detection of HPV-Associated Head and Neck Cancers.

Advances in Prevention, Screening, and Early Detection of HPV-Associated Head and Neck Cancers.

Journal: Viruses

Published: August 05, 2025

Showing 1-12 of 210

Last Updated: 09/26/2026